Immunogenicity of protein aldehydes

Immunogenicity of protein aldehydes

<p>Protein carbonylation introduces diverse non-enzymatic post-translational modifications (PTMs) containing aldehydes and ketones (reactive carbonyls) during oxidative or glycative stress, and is a hallmark of unhealthy ageing and various neurological, cardiovascular, respiratory, musculoskel...

Bibliografske podrobnosti
Glavni avtor:	Li Jovanoska, L
Drugi avtorji:	Sattentau, Q
Format:	Thesis
Jezik:	English
Izdano:	2022
Teme:	immunology

Podobne knjige/članki

Immunoinformatics : predicting immunogenicity in silico /
od: Flower, Darren R.

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
od: Puthupparampil V. Scaria, et al.
Izdano: (2022-08-01)

Identification and immunogenicity study of soluble protein derived from Pasteurella multocida serotype B / Noor Masyitah Jumahat
od: Jumahat, Noor Masyitah
Izdano: (2015)

Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
od: Nya L. Fraleigh, et al.
Izdano: (2016-08-01)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
od: Tomomi Hirama, et al.
Izdano: (2021-07-01)

Immunogenicity of vaccines for malaria-exposed populations
od: Bowyer, GSA
Izdano: (2018)

Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant
od: Junhao Fan, et al.
Izdano: (2024-08-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
od: Pinpathomrat, N
Izdano: (2018)

Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
od: Vitaliy A. Matveev, et al.
Izdano: (2023-10-01)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
od: Diggle, L, et al.
Izdano: (2006)

Mechanisms that promote the evolution of cross-reactive antibodies upon vaccination with designed influenza immunogens
od: Leerang Yang, et al.
Izdano: (2023-03-01)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
od: Shin Kobayashi, et al.
Izdano: (2023-08-01)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
od: Jun-Gyu Park, et al.
Izdano: (2021-09-01)

Comparison of Staphylococcus aureus surface protein extraction methods and immunogenicity
od: Reta Duguma Abdi, et al.
Izdano: (2019-10-01)

Single-molecule and super-resolved imaging deciphers membrane behavior of onco-immunogenic CCR5
od: Patrick Hunter, et al.
Izdano: (2022-12-01)

The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant used
od: D.J. Begg, et al.
Izdano: (2019-06-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
od: Sarah E. Cummings, et al.
Izdano: (2024-01-01)

T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T cells with specificities against immunogenic viral antigens
od: Daniel G. Chen, et al.
Izdano: (2023-11-01)

Concomitant inhibition of PPARγ and mTORC1 induces the differentiation of human monocytes into highly immunogenic dendritic cells
od: Fernando Erra Diaz, et al.
Izdano: (2023-03-01)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
od: Masayuki Aboshi, et al.
Izdano: (2024-02-01)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
od: Jonas P. Becker, et al.
Izdano: (2021-04-01)

Network analysis uncovers the communication structure of SARS-CoV-2 spike protein identifying sites for immunogen design
od: Pedro D. Manrique, et al.
Izdano: (2023-01-01)

Gold Nanoclusters Display Low Immunogenic Effect in Microglia Cells
od: Joanna Sobska, et al.
Izdano: (2021-04-01)

Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis
od: Santosh Kumar, et al.
Izdano: (2021-02-01)

The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
od: Jean-Pierre Bikorimana, et al.
Izdano: (2022-12-01)

A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
od: Ebony N. Gary, et al.
Izdano: (2021-07-01)

Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial
od: Majela Gonzalez-Miro, et al.
Izdano: (2023-03-01)

PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy
od: Kaimin Xiao, et al.
Izdano: (2024-11-01)

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of <italic toggle="yes">Shigella</italic> Artificial Invaplex
od: K. Ross Turbyfill, et al.
Izdano: (2018-04-01)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
od: Lee, Y, et al.
Izdano: (2006)

Vaccine Immunogenicity versus Gastrointestinal Microbiome Status: Implications for Poultry Production
od: Chrysta N. Beck, et al.
Izdano: (2024-02-01)

Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers
od: Pei-Lan Shao, et al.
Izdano: (2006-01-01)

A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer
od: Hong-Yang Zhao, et al.
Izdano: (2024-01-01)

Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity
od: Taiki Moriya, et al.
Izdano: (2021-05-01)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
od: de Cassan, S
Izdano: (2011)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
od: Alharbi, N
Izdano: (2014)

Structure-guided design of an IL-1β immunogen for the treatment of autoinflammatory diseases
od: Sousa Augusto, G
Izdano: (2024)

Antiviral functions of bone morphogenetic proteins and the activins
od: Al-Hourani, K
Izdano: (2015)

Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profile
od: Paul Chamberlain, et al.
Izdano: (2024-12-01)

Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7
od: Tan, Geok Hun, et al.
Izdano: (2005)